Physician profile
Robert Young Kim
NPI 1477598506
$1,588.26
in general payments reported to CMS, 2019-2025
8 companies · $32.09 in 2025
The $32.09 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2021: $319 · 2022: $469 · 2023: $208 · 2024: $281 · 2025: $32.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $432.62 | 2021-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Obsidio |
| Abbott Laboratories | $343.22 | 2021-2022 | |
| Stryker Corporation | $305.55 | 2019-2024 | Target |
| Penumbra, INC. | $286.38 | 2021-2024 | Indigo System |
| Cook Medical LLC | $120.60 | 2019 | |
| Chiesi USA, INC. | $48.38 | 2022 | |
| Ethicon US, LLC | $32.09 | 2025 | Neuwave |
| Angiodynamics, INC. | $19.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.